Aug 6, 2026 05:41PM
Aug 6, 2026 04:01PM
Jul 27, 2026 04:01PM
Jul 9, 2026 04:01PM
Jun 18, 2026 08:00AM
Jun 18, 2026 08:00AM
May 21, 2026 06:00PM Biogen and Denali discontinue Parkinson's drug after trial fails
May 21, 2026 06:00PM
May 7, 2026 05:57PM
May 7, 2026 04:01PM
Apr 20, 2026 08:30AM
Apr 6, 2026 05:55AM
Apr 3, 2026 01:30PM
Mar 25, 2026 11:50AM Denali Therapeutics gains FDA approval for Hunter syndrome drug AVLAYAH
Mar 25, 2026 11:50AM
Feb 26, 2026 05:21PM
Feb 26, 2026 04:01PM
Dec 30, 2025 08:00AM
Dec 30, 2025 08:00AM
Dec 4, 2025 07:10AM
Dec 4, 2025 07:02AM Denali Therapeutics secures $275 million royalty deal with Royalty Pharma
Dec 4, 2025 07:00AM
Nov 6, 2025 06:48PM
Nov 6, 2025 04:01PM
Nov 6, 2025 04:00PM
Nov 6, 2025 04:00PM
Oct 13, 2025 04:01PM
Oct 13, 2025 04:01PM Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome)
Aug 11, 2025 04:03PM
Aug 11, 2025 04:01PM
Jul 7, 2025 08:03AM
Jul 7, 2025 08:00AM
May 6, 2025 05:38PM
May 6, 2025 04:01PM
Apr 2, 2025 08:04AM Denali Therapeutics (DNLI) Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on
Apr 2, 2025 08:00AM
Feb 27, 2025 05:02PM
Feb 27, 2025 04:01PM
Nov 6, 2024 04:01PM
Aug 1, 2024 08:51AM
Aug 1, 2024 06:45AM
May 7, 2024 06:35PM Denali Therapeutics Inc. (DNLI) Tops Q1 EPS by 2c
May 7, 2024 04:01PM
Feb 27, 2024 09:30AM
Feb 27, 2024 08:05AM
Jan 8, 2024 08:00AM
Nov 7, 2023 05:23PM
Nov 7, 2023 04:01PM
Aug 8, 2023 05:18PM Denali Therapeutics Inc. (DNLI) Tops Q2 EPS by 199c
Aug 8, 2023 04:01PM

1,216,218 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All